Health ❯Healthcare ❯Pharmaceuticals ❯Drug Development

Obesity Treatments

Pharmaceuticals Clinical Trials Pharmaceutical Industry Research and Development Market Competition Patient Care Drug Market Adverse Effects Medication Adherence Treatment Options

4 ARTICLES

3w ago

Amgen’s MariTide Delivers 20% Weight Loss in Phase 2 and Advances to 72-Week Phase 3 Trial

Amgen plans a 72-week pivotal study following phase 2 results that showed substantial weight loss alongside lower gastrointestinal side effects from a low-dose ramp-up.

12 ARTICLES

3mo ago

Pfizer Halts Development of Oral Weight-Loss Pill After Liver Injury

3 ARTICLES

4mo ago

Amgen Advances Weight-Loss Drug MariTide with Two Phase 3 Trials